IDEAYA Biosciences (IDYA) Change in Acquisitions & Divestments (2023 - 2026)

IDEAYA Biosciences has disclosed Change in Acquisitions & Divestments across 4 years of filings, most recently posting $162.5 million for Q1 2026.

• Change in Acquisitions & Divestments for Q1 2026 came in at $162.5 million, down 12.78% year-over-year; the trailing twelve-month figure through Mar 2026 was $656.4 million (down 13.15% YoY), and the FY2025 annual result was $680.2 million, down 1.79% from the prior year.
• Change in Acquisitions & Divestments came in at $162.5 million for Q1 2026 at IDEAYA Biosciences, up from $138.9 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $234.3 million in Q2 2024 to a low of $95.9 million in Q1 2023.
• The 4-year median for Change in Acquisitions & Divestments is $141.0 million (2024), against an average of $151.9 million.
• Across the five-year window, Change in Acquisitions & Divestments soared 134.88% in 2024 and decreased 25.68% in 2025, its largest moves.
• IDEAYA Biosciences' Change in Acquisitions & Divestments stood at $110.5 million in 2023, then climbed by 27.63% to $141.0 million in 2024, then decreased by 1.48% to $138.9 million in 2025, then advanced by 16.97% to $162.5 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $162.5 million (Q1 2026), $138.9 million (Q4 2025), and $180.8 million (Q3 2025), per Business Quant data.